T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells
Differentiation · 2023
DOI: 10.1016/j.diff.2023.01.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Differentiation, 2023. Verfasst von Su Hang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Pluripotent Stem Cells, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong; Centre for Translational Stem Cell Biology, Hong Kong. Electronic address: rios@hku.hk.
Zitieren
APA
Hang, S., Wang, N., & Sugimura, R. (2023). T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation. https://doi.org/10.1016/j.diff.2023.01.001
Vancouver
Hang S, Wang N, Sugimura R. T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation. 2023. doi:10.1016/j.diff.2023.01.001
BibTeX
@article{Hang2023,
author = {Hang, Su and Wang, Nan and Sugimura, Ryohichi},
title = {T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells},
journal = {Differentiation},
year = {2023},
doi = {10.1016/j.diff.2023.01.001}
}
EUVIMED